Skip to main content
Clinical Trials/NCT02823249
NCT02823249CompletedNot Applicable

Effect of Amino Acids and Sugar Alcohols on Release of Satiation Peptides and Activation of Specific Brain Regions in Normal Weight and Obese Subjects

University Hospital, Basel, Switzerland1 site in 1 country20 target enrollmentStarted: May 1, 2014Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
20
Locations
1
Primary Endpoint
Effect of aminoacids on cerebral blood flow measured by functional brain MRI

Study Overview

Brief Summary

With this study the investigators investigate the effects of amino acids (tryptophan, leucin) and sugar alcohols (xylitol, erythritol) on satiety mechanisms and brain activation.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Prevention
Masking
Double (Participant, Investigator)

Eligibility Criteria

Ages
18 Years to 40 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Healthy normal weight subjects with a body-mass index of 19.0-24.9
  • •Healthy obese subjects with a body-mass index of > 30
  • •Normal eating habits (no diets; no dietary changes; no special dietary habits such as vegetarian/vegan)
  • •Age 18-40 years
  • •Stable body weight for at least three months

Exclusion Criteria

  • •Substance abuse
  • •Regular intake of medications (except for oral contraceptives)
  • •Medical or psychiatric illness
  • •History of gastrointestinal disorders
  • •Food allergies
  • •Pregnancy, breast feeding
  • •Body piercings that cannot be removed
  • •History of claustrophobia
  • •Left-hander

Arms & Interventions

1.56 g L-Tryptophan

Active Comparator

1.56 g L-Tryptophan in 300 mL tap water given via nasogastric tube

  • after 60 min: 500ml of a mixed liquid meal (Ensure Plus®; 17% protein, 29% fat and 54% carbohydrate) given via nasogastric tube

Intervention: Tap water (Dietary Supplement)

1.56 g L-Leucine

Active Comparator

1.56 g L-Leucine in 300 mL tap water given via nasogastric tube

  • after 60 min: 500ml of a mixed liquid meal (Ensure Plus®; 17% protein, 29% fat and 54% carbohydrate) given via nasogastric tube

Intervention: Tap water (Dietary Supplement)

Tap water and mixed liquid meal

Placebo Comparator

300 mL tap water given via nasogastric tube

  • after 60 min: 500ml of a mixed liquid meal (Ensure Plus®; 17% protein, 29% fat and 54% carbohydrate) given via nasogastric tube

Intervention: Tap water (Dietary Supplement)

1.56 g L-Tryptophan

Active Comparator

1.56 g L-Tryptophan in 300 mL tap water given via nasogastric tube

  • after 60 min: 500ml of a mixed liquid meal (Ensure Plus®; 17% protein, 29% fat and 54% carbohydrate) given via nasogastric tube

Intervention: Nasogastric Tube (Device)

1.56 g L-Tryptophan

Active Comparator

1.56 g L-Tryptophan in 300 mL tap water given via nasogastric tube

  • after 60 min: 500ml of a mixed liquid meal (Ensure Plus®; 17% protein, 29% fat and 54% carbohydrate) given via nasogastric tube

Intervention: 1.56 g L-Tryptophan (Dietary Supplement)

1.56 g L-Tryptophan

Active Comparator

1.56 g L-Tryptophan in 300 mL tap water given via nasogastric tube

  • after 60 min: 500ml of a mixed liquid meal (Ensure Plus®; 17% protein, 29% fat and 54% carbohydrate) given via nasogastric tube

Intervention: Mixed liquid meal (Ensure Plus®; 17% protein, 29% fat and 54% carbohydrate) (Dietary Supplement)

1.56 g L-Leucine

Active Comparator

1.56 g L-Leucine in 300 mL tap water given via nasogastric tube

  • after 60 min: 500ml of a mixed liquid meal (Ensure Plus®; 17% protein, 29% fat and 54% carbohydrate) given via nasogastric tube

Intervention: Mixed liquid meal (Ensure Plus®; 17% protein, 29% fat and 54% carbohydrate) (Dietary Supplement)

1.56 g L-Leucine

Active Comparator

1.56 g L-Leucine in 300 mL tap water given via nasogastric tube

  • after 60 min: 500ml of a mixed liquid meal (Ensure Plus®; 17% protein, 29% fat and 54% carbohydrate) given via nasogastric tube

Intervention: Nasogastric Tube (Device)

1.56 g L-Leucine

Active Comparator

1.56 g L-Leucine in 300 mL tap water given via nasogastric tube

  • after 60 min: 500ml of a mixed liquid meal (Ensure Plus®; 17% protein, 29% fat and 54% carbohydrate) given via nasogastric tube

Intervention: 1.56 g L-Leucine (Dietary Supplement)

50 g Xylitol

Active Comparator

50 g Xylitol in 300 mL tap water given via nasogastric tube

Intervention: 50 g Xylitol (Dietary Supplement)

50 g Xylitol

Active Comparator

50 g Xylitol in 300 mL tap water given via nasogastric tube

Intervention: Nasogastric Tube (Device)

75 g Erythritol

Active Comparator

75 g Erythritol in 300 mL tap water given via nasogastric tube

Intervention: 75 g Erythritol (Dietary Supplement)

75 g Erythritol

Active Comparator

75 g Erythritol in 300 mL tap water given via nasogastric tube

Intervention: Nasogastric Tube (Device)

75 g Glucose and mixed liquid meal

Placebo Comparator

75 g Glucose in 300 mL tap water given via nasogastric tube

  • after 60 min: 500ml of a mixed liquid meal (Ensure Plus®; 17% protein, 29% fat and 54% carbohydrate) given via nasogastric tube

Intervention: 75 g Glucose (Dietary Supplement)

75 g Glucose and mixed liquid meal

Placebo Comparator

75 g Glucose in 300 mL tap water given via nasogastric tube

  • after 60 min: 500ml of a mixed liquid meal (Ensure Plus®; 17% protein, 29% fat and 54% carbohydrate) given via nasogastric tube

Intervention: Mixed liquid meal (Ensure Plus®; 17% protein, 29% fat and 54% carbohydrate) (Dietary Supplement)

75 g Glucose and mixed liquid meal

Placebo Comparator

75 g Glucose in 300 mL tap water given via nasogastric tube

  • after 60 min: 500ml of a mixed liquid meal (Ensure Plus®; 17% protein, 29% fat and 54% carbohydrate) given via nasogastric tube

Intervention: Nasogastric Tube (Device)

Tap water and mixed liquid meal

Placebo Comparator

300 mL tap water given via nasogastric tube

  • after 60 min: 500ml of a mixed liquid meal (Ensure Plus®; 17% protein, 29% fat and 54% carbohydrate) given via nasogastric tube

Intervention: Mixed liquid meal (Ensure Plus®; 17% protein, 29% fat and 54% carbohydrate) (Dietary Supplement)

Tap water and mixed liquid meal

Placebo Comparator

300 mL tap water given via nasogastric tube

  • after 60 min: 500ml of a mixed liquid meal (Ensure Plus®; 17% protein, 29% fat and 54% carbohydrate) given via nasogastric tube

Intervention: Nasogastric Tube (Device)

50 g Xylitol

Active Comparator

50 g Xylitol in 300 mL tap water given via nasogastric tube

Intervention: Tap water (Dietary Supplement)

75 g Glucose and mixed liquid meal

Placebo Comparator

75 g Glucose in 300 mL tap water given via nasogastric tube

  • after 60 min: 500ml of a mixed liquid meal (Ensure Plus®; 17% protein, 29% fat and 54% carbohydrate) given via nasogastric tube

Intervention: Tap water (Dietary Supplement)

75 g Erythritol

Active Comparator

75 g Erythritol in 300 mL tap water given via nasogastric tube

Intervention: Tap water (Dietary Supplement)

Outcomes

Primary Outcomes

Effect of aminoacids on cerebral blood flow measured by functional brain MRI

Time Frame: changes from baseline to one hour after treatment

Effect of sugar alcohols on cerebral blood flow measured by functional brain MRI

Time Frame: changes from baseline to one hour after treatment

Secondary Outcomes

  • Measurement of Plasma PYY concentrations(changes from baseline to three hours after treatment)
  • Measurement of Plasma ghrelin concentrations(changes from baseline to three hours after treatment)
  • Measurement of Plasma Glucose concentrations(changes from baseline to three hours after treatment)
  • Measurement of Plasma Insulin concentrations(changes from baseline to three hours after treatment)
  • Measurement of Plasma cholecystokinin concentrations(changes from baseline to three hours after treatment)
  • Measurement of Plasma Glucagon-like Peptide (GLP-1) concentrations(changes from baseline to three hours after treatment)

Investigators

Sponsor
University Hospital, Basel, Switzerland
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials